Gene · 407026
Papers3,863
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,863
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond the Mat: Exploring the Potential Clinical Benefits of Yoga on Epigenetics and Gene Expression: A Narrative Review of the Current Scientific Evidence. | Int J Yoga | 2023 | 38204768 | PubTator, text mining | PubMed |
| TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets. | Int J Mol Sci | 2023 | 38203443 | PubTator, text mining | PubMed |
| Small RNA signatures of the anterior cruciate ligament from patients with knee joint osteoarthritis. | Front Mol Biosci | 2023 | 38187089 | PubTator, text mining | PubMed |
| Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer. | Front Oncol | 2023 | 38169723 | PubTator, text mining | PubMed |
| Retracted: miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway. | Appl Bionics Biomech | 2023 | 38152754 | PubTator, text mining | PubMed |
| Transcriptome studies of congenital heart diseases: identifying current gaps and therapeutic frontiers. | Front Genet | 2023 | 38152655 | PubTator, text mining | PubMed |
| Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients. | Front Immunol | 2023 | 38152407 | PubTator, text mining | PubMed |
| miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy. | Curr Issues Mol Biol | 2023 | 38132441 | PubTator, text mining | PubMed |
| Integrated Analysis of lncRNA-miRNA-mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits. | Cells | 2023 | 38132140 | PubTator, text mining | PubMed |
| ncRNAs: an unexplored cellular defense mechanism in leprosy. | Front Genet | 2023 | 38116294 | PubTator, text mining | PubMed |
| miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD. | Open Med (Wars) | 2023 | 38075030 | PubTator, text mining | PubMed |
| Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer. | Cancers (Basel) | 2023 | 38067280 | PubTator, text mining | PubMed |
| MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches? | Cancers (Basel) | 2023 | 38067261 | PubTator, text mining | PubMed |
| miR-29c-3p represses the angiogenesis of esophageal squamous cell carcinoma by targeting SERPINH1 to regulate the Wnt signaling pathway. | Acta Cir Bras | 2023 | 38055382 | PubTator, text mining | PubMed |
| Urinary exosomal miRNA signature of IgA nephropathy: a case-control study. | Sci Rep | 2023 | 38049447 | PubTator, text mining | PubMed |
| Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells. | Heliyon | 2023 | 38046164 | PubTator, text mining | PubMed |
| The physiological functions and therapeutic potential of exosomes during the development and treatment of polycystic ovary syndrome. | Front Physiol | 2023 | 38028777 | PubTator, text mining | PubMed |
| Characterization of lncRNA-associated ceRNA network to uncover novel potential biomarkers in coronary artery disease. | Medicine (Baltimore) | 2023 | 38013355 | PubTator, text mining | PubMed |
| Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer. | Nat Commun | 2023 | 38012143 | PubTator, text mining | PubMed |
| Entecavir: A Review and Considerations for Its Application in Oncology. | Pharmaceuticals (Basel) | 2023 | 38004468 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/407026/papers?page=7